Glaxo’s Cervarix vaccine faces further delay
Published by Food and Drug Administration News June 30th, 2008 in UncategorizedGlaxoSmithKline Plc does not expect to win U.S. approval for its key cervical cancer vaccine Cervarix until late 2009, marking a further delay for the product.